Nutex Health Q2 2025: Explosive Growth & Micro-Hospitals

Nutex Healths Q2 2025 results are scorching hot, with revenue surging 220% to $244 million and patient visits up 10.6% to 45,573. The companys micro-hospital model and strategic revenue plays under the No Surprises Act are driving this growth. Despite a delay in filing their quarterly report due to reclassifying stock comp as a liability, Nutex remains cash-rich with $96.7 million on hand. The company is expanding with over 15 hospital projects, two new openings by year-end, and IPA expansions for value-based care. A $25 million stock buyback was also approved. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/83236d56664d599f